Article Commentary: New Treatment Targets for Psoriasis: Steering Patients and Providers toward Better Treatment Outcomes

Abstract

Keywords

biologics body surface area psoriasis outcome measures treat to target treatment treatment goals

Get full access to this article

View all access options for this article.

References

Armstrong

A.W.

Siegel

M.P.

Bagel

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.

J Am Acad Dermatol. 2017 Feb; 76(2): 290–298. doi: 10.1016/j.jaad.2016.10.017. Epub 2016 Nov 28.

Coates

L.C.

Navarro-Coy

Brown

S.R.

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis.

BMC Musculoskelet Disord. 2013 Mar 21;14: 101. doi: 10.1186/1471-2474-14-101.

Gulliver

Lynde

Dutz

J.P.

Think beyond the Skin 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.

J Cutan Med Surg. 2015 Jan-Feb; 19(1): 22–7. doi: 10.2310/7750.2014.13151. Epub 2015 Jan 1.

Mrowietz

Kragballe

Reich

Definition of treatment goals for moderate to severe psoriasis: a European consensus.

Arch Dermatol Res. 2011 Jan; 303(1): 1–10. doi: 10.1007/s00403-010-1080-1. Epub 2010 Sep 21.

Armstrong

A.W.

Schupp

Bebo

. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011. PLoS One. 2012; 7(12): e52935. doi: 10.1371/journal.pone.0052935. Epub 2012 Dec 28.

Armstrong

A.W.

Robertson

A.D.

Schupp

Lebwohl

M.G.

. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013 Oct; 149(10): 1180–5. doi: 10.1001/jamadermatol.2013.5264.